QCP Services

  - Network Services

  - Utilization Management

  - Large Case Management

  - Disease Management
       - Diabetic Disease  Management
       - Respiratory
Disease
Management

  - QCP Rx - Pharmacy Benefit Management

  - HealthPhone

  - Outcomes &
Data Management

Request Information

  - Requirements for
a Group Quote


Respiratory Disease Management

Our Respiratory Disease Management program is designed to assist your employees that have Asthma or Chronic Obstructive Pulmonary Disease (COPD). Management of the disease keeps employees healthy and working; resulting in fewer days lost to poor health and greater productivity. Through effective management people that are afflicted with respiratory issues can lead healthy and active lives, making them more productive members of your workforce.

Asthma

More Americans than ever before are suffering from asthma. It is one of this country's most common and costly diseases. Asthma is a disease of the lungs in which the airways become blocked or narrowed causing breathing difficulty. Asthma is commonly divided into two types: allergic (extrinsic) asthma and non-allergic (intrinsic) asthma. There is still much research that needs to be done to fully understand how to prevent, treat and cure asthma. But, with proper management, people can live healthy and active lives.

More than an estimated 20 million people in the United States have asthma. This health problem results in thousands of hospital stays each year. Each year billions of dollars are spent on the treatment of asthma. Symptoms include difficulty breathing, wheezing, coughing and tightness in the chest. In severe cases, asthma can be deadly.

In America:

  • For adults, asthma is the fourth leading cause of work absenteeism resulting in nearly 10 million missed or lost workdays each year, resulting in a total cost of nearly $5 billion in total lost productivity.
  • Asthma accounts for one-quarter of all emergency room visits in the U.S. each year.
  • Asthma is the third-ranking cause of hospitalization in children.
  • The annual cost of asthma is estimated to be nearly $20 billion.

COPD

Chronic Obstructive Pulmonary Disease (COPD) is a term referring to two lung diseases, chronic bronchitis and emphysema, that are characterized by obstruction to airflow that interferes with normal breathing. Both of these conditions frequently co-exist, hence physicians prefer the term COPD.

There are an estimated 12 million people in the United States who have COPD. It is likely that an additional 12 million or more COPD cases (those in patients with minimal or no symptoms at all) are undiagnosed. Thus, the true prevalence of COPD may be as high as 24 million cases.

  • COPD is the fourth leading cause of death in America.
  • In 2007, the cost to the nation for COPD was approximately $42.6 billion, including $26.7 billion in direct health care expenditures, $8.0 billion in indirect morbidity and $7.9 billion in indirect mortality costs.


Quality Care Partners' Respiratory Disease Management Program is a unique model which centers on the patient and includes coordination of care through the physician, education, community pharmacists, the employer and the QCP Disease Management Department. Through monthly intervention with a community pharmacist, visits with their physician and contact with QCP, participants learn how to better manage their disease and enjoy a healthier, happier lifestyle.

Employers who provide a respiratory disease management program for their employees realize demonstrated dollar-for-dollar savings by reducing the number of emergency room visits and hospitalizations due to asthma and COPD. Beyond this, the incalculable benefits of reduced absenteeism and improved productivity translate into higher margins and happier, healthier workplace environments. To learn more about our Respiratory Disease Management Program and how we can help your employees lead healthier, happier, more productive lives, contact us for more information.